Thus, IL-6/STAT-3 signaling could contribute to FOLFIRI-related mucosal damage by controlling the proliferation and survival of intestinal epithelial cells as observed in colitis (Moriasi et al., 2012; Nguyen et al., 2015). This evidence concerns the gene IL6 and colitis.